Shanghai Time Outside to Reduce Myopia trial: design and baseline data
Importance Myopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia. Background To describe the methodology and baseline data of the Shanghai Time Outside to Reduce Myopia (STORM) trial. Design A 2‐year, school‐based, prospective...
Gespeichert in:
| Veröffentlicht in: | Clinical & experimental ophthalmology Jg. 47; H. 2; S. 171 - 178 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Melbourne
John Wiley & Sons Australia, Ltd
01.03.2019
Wiley Subscription Services, Inc |
| Schlagworte: | |
| ISSN: | 1442-6404, 1442-9071, 1442-9071 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Importance
Myopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia.
Background
To describe the methodology and baseline data of the Shanghai Time Outside to Reduce Myopia (STORM) trial.
Design
A 2‐year, school‐based, prospective, cluster randomized trial.
Participants
Children from grade I and II classes of 24 schools from eight districts in Shanghai, China, were randomized to either a control group, a test group I (40‐min outdoor time/day) or test group II (80‐min outdoor time/day).
Methods
At baseline and annual intervals, cycloplegic autorefraction and axial length measurement will be performed. Time outdoors and light exposure will be monitored via parent/carer questionnaires and a wearable device.
Main Outcome Measures
Spherical equivalent, prevalence of myopia and time outdoors in each group.
Results
A total of 6295 eligible children (age 7.2 ± 0.7 y [6‐9 y]) were randomized to control (n = 2037), test group I (n = 2329) and test group II (n = 1929). At baseline, spherical equivalent was +0.98 ± 1.02D, +1.02 ± 1.02D and +1.00 ± 0.99D (P = 0.708), myopia prevalence was 8.9, 7.7 and 7.8% (P = 0.270) and time outdoors was 58.5 ± 35.8, 59.8 ± 34.7 and 58.5 ± 35.3 min/d (P = 0.886) for control, test groups I and II, respectively.
Conclusions and Relevance
Myopia prevalence was high at nearly 8 to 9% in school children aged 7 years in Shanghai, China. The current trial will help evaluate if increased time outdoors has a role to play in reducing the incidence of myopia and/or slow the progression of myopia. |
|---|---|
| AbstractList | Importance
Myopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia.
Background
To describe the methodology and baseline data of the Shanghai Time Outside to Reduce Myopia (STORM) trial.
Design
A 2‐year, school‐based, prospective, cluster randomized trial.
Participants
Children from grade I and II classes of 24 schools from eight districts in Shanghai, China, were randomized to either a control group, a test group I (40‐min outdoor time/day) or test group II (80‐min outdoor time/day).
Methods
At baseline and annual intervals, cycloplegic autorefraction and axial length measurement will be performed. Time outdoors and light exposure will be monitored via parent/carer questionnaires and a wearable device.
Main Outcome Measures
Spherical equivalent, prevalence of myopia and time outdoors in each group.
Results
A total of 6295 eligible children (age 7.2 ± 0.7 y [6‐9 y]) were randomized to control (n = 2037), test group I (n = 2329) and test group II (n = 1929). At baseline, spherical equivalent was +0.98 ± 1.02D, +1.02 ± 1.02D and +1.00 ± 0.99D (P = 0.708), myopia prevalence was 8.9, 7.7 and 7.8% (P = 0.270) and time outdoors was 58.5 ± 35.8, 59.8 ± 34.7 and 58.5 ± 35.3 min/d (P = 0.886) for control, test groups I and II, respectively.
Conclusions and Relevance
Myopia prevalence was high at nearly 8 to 9% in school children aged 7 years in Shanghai, China. The current trial will help evaluate if increased time outdoors has a role to play in reducing the incidence of myopia and/or slow the progression of myopia. Myopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia. To describe the methodology and baseline data of the Shanghai Time Outside to Reduce Myopia (STORM) trial. A 2-year, school-based, prospective, cluster randomized trial. Children from grade I and II classes of 24 schools from eight districts in Shanghai, China, were randomized to either a control group, a test group I (40-min outdoor time/day) or test group II (80-min outdoor time/day). At baseline and annual intervals, cycloplegic autorefraction and axial length measurement will be performed. Time outdoors and light exposure will be monitored via parent/carer questionnaires and a wearable device. Spherical equivalent, prevalence of myopia and time outdoors in each group. A total of 6295 eligible children (age 7.2 ± 0.7 y [6-9 y]) were randomized to control (n = 2037), test group I (n = 2329) and test group II (n = 1929). At baseline, spherical equivalent was +0.98 ± 1.02D, +1.02 ± 1.02D and +1.00 ± 0.99D (P = 0.708), myopia prevalence was 8.9, 7.7 and 7.8% (P = 0.270) and time outdoors was 58.5 ± 35.8, 59.8 ± 34.7 and 58.5 ± 35.3 min/d (P = 0.886) for control, test groups I and II, respectively. Myopia prevalence was high at nearly 8 to 9% in school children aged 7 years in Shanghai, China. The current trial will help evaluate if increased time outdoors has a role to play in reducing the incidence of myopia and/or slow the progression of myopia. Myopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia.IMPORTANCEMyopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia.To describe the methodology and baseline data of the Shanghai Time Outside to Reduce Myopia (STORM) trial.BACKGROUNDTo describe the methodology and baseline data of the Shanghai Time Outside to Reduce Myopia (STORM) trial.A 2-year, school-based, prospective, cluster randomized trial.DESIGNA 2-year, school-based, prospective, cluster randomized trial.Children from grade I and II classes of 24 schools from eight districts in Shanghai, China, were randomized to either a control group, a test group I (40-min outdoor time/day) or test group II (80-min outdoor time/day).PARTICIPANTSChildren from grade I and II classes of 24 schools from eight districts in Shanghai, China, were randomized to either a control group, a test group I (40-min outdoor time/day) or test group II (80-min outdoor time/day).At baseline and annual intervals, cycloplegic autorefraction and axial length measurement will be performed. Time outdoors and light exposure will be monitored via parent/carer questionnaires and a wearable device.METHODSAt baseline and annual intervals, cycloplegic autorefraction and axial length measurement will be performed. Time outdoors and light exposure will be monitored via parent/carer questionnaires and a wearable device.Spherical equivalent, prevalence of myopia and time outdoors in each group.MAIN OUTCOME MEASURESSpherical equivalent, prevalence of myopia and time outdoors in each group.A total of 6295 eligible children (age 7.2 ± 0.7 y [6-9 y]) were randomized to control (n = 2037), test group I (n = 2329) and test group II (n = 1929). At baseline, spherical equivalent was +0.98 ± 1.02D, +1.02 ± 1.02D and +1.00 ± 0.99D (P = 0.708), myopia prevalence was 8.9, 7.7 and 7.8% (P = 0.270) and time outdoors was 58.5 ± 35.8, 59.8 ± 34.7 and 58.5 ± 35.3 min/d (P = 0.886) for control, test groups I and II, respectively.RESULTSA total of 6295 eligible children (age 7.2 ± 0.7 y [6-9 y]) were randomized to control (n = 2037), test group I (n = 2329) and test group II (n = 1929). At baseline, spherical equivalent was +0.98 ± 1.02D, +1.02 ± 1.02D and +1.00 ± 0.99D (P = 0.708), myopia prevalence was 8.9, 7.7 and 7.8% (P = 0.270) and time outdoors was 58.5 ± 35.8, 59.8 ± 34.7 and 58.5 ± 35.3 min/d (P = 0.886) for control, test groups I and II, respectively.Myopia prevalence was high at nearly 8 to 9% in school children aged 7 years in Shanghai, China. The current trial will help evaluate if increased time outdoors has a role to play in reducing the incidence of myopia and/or slow the progression of myopia.CONCLUSIONS AND RELEVANCEMyopia prevalence was high at nearly 8 to 9% in school children aged 7 years in Shanghai, China. The current trial will help evaluate if increased time outdoors has a role to play in reducing the incidence of myopia and/or slow the progression of myopia. ImportanceMyopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia.BackgroundTo describe the methodology and baseline data of the Shanghai Time Outside to Reduce Myopia (STORM) trial.DesignA 2‐year, school‐based, prospective, cluster randomized trial.ParticipantsChildren from grade I and II classes of 24 schools from eight districts in Shanghai, China, were randomized to either a control group, a test group I (40‐min outdoor time/day) or test group II (80‐min outdoor time/day).MethodsAt baseline and annual intervals, cycloplegic autorefraction and axial length measurement will be performed. Time outdoors and light exposure will be monitored via parent/carer questionnaires and a wearable device.Main Outcome MeasuresSpherical equivalent, prevalence of myopia and time outdoors in each group.ResultsA total of 6295 eligible children (age 7.2 ± 0.7 y [6‐9 y]) were randomized to control (n = 2037), test group I (n = 2329) and test group II (n = 1929). At baseline, spherical equivalent was +0.98 ± 1.02D, +1.02 ± 1.02D and +1.00 ± 0.99D (P = 0.708), myopia prevalence was 8.9, 7.7 and 7.8% (P = 0.270) and time outdoors was 58.5 ± 35.8, 59.8 ± 34.7 and 58.5 ± 35.3 min/d (P = 0.886) for control, test groups I and II, respectively.Conclusions and RelevanceMyopia prevalence was high at nearly 8 to 9% in school children aged 7 years in Shanghai, China. The current trial will help evaluate if increased time outdoors has a role to play in reducing the incidence of myopia and/or slow the progression of myopia. |
| Author | Naduvilath, Thomas Li, Wayne Weng, Rebecca Zou, Haidong Resnikoff, Serge Sankaridurg, Padmaja Xiong, Shuyu Zhang, Bo Xu, Xun Zhu, Jianfeng He, Xiangui |
| Author_xml | – sequence: 1 givenname: Xiangui orcidid: 0000-0002-8938-1879 surname: He fullname: He, Xiangui organization: Fudan University – sequence: 2 givenname: Padmaja surname: Sankaridurg fullname: Sankaridurg, Padmaja organization: University of New South Wales, Sydney – sequence: 3 givenname: Shuyu surname: Xiong fullname: Xiong, Shuyu organization: Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai Key Laboratory of Ocular Fundus Diseases – sequence: 4 givenname: Wayne surname: Li fullname: Li, Wayne organization: Brien Holden Vision Institute – sequence: 5 givenname: Bo surname: Zhang fullname: Zhang, Bo organization: Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital – sequence: 6 givenname: Rebecca surname: Weng fullname: Weng, Rebecca organization: Brien Holden Vision Institute – sequence: 7 givenname: Jianfeng orcidid: 0000-0002-4453-611X surname: Zhu fullname: Zhu, Jianfeng organization: Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital – sequence: 8 givenname: Thomas surname: Naduvilath fullname: Naduvilath, Thomas organization: Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai Key Laboratory of Ocular Fundus Diseases – sequence: 9 givenname: Serge surname: Resnikoff fullname: Resnikoff, Serge organization: Brien Holden Vision Institute – sequence: 10 givenname: Haidong surname: Zou fullname: Zou, Haidong organization: Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai Key Laboratory of Ocular Fundus Diseases – sequence: 11 givenname: Xun orcidid: 0000-0002-4246-4343 surname: Xu fullname: Xu, Xun email: drxuxun@sjtu.edu.cn organization: Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai Key Laboratory of Ocular Fundus Diseases |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30207041$$D View this record in MEDLINE/PubMed |
| BookMark | eNp10c1OGzEUBWCrApWfdtEXqCx1UxYJvrYzrrtDEQEkUCRK19ad8R0wmtjpeEZV3h5DwgaBF7YX3z2yfI7YXkyRGPsGYgplnTaUpqCUhU_sELSWEysM7O3ulRb6gB3l_CiEmElVfWYHSkhhhIZDtvjzgPH-AQO_Cyviy3HIwRMfEr8lPzbEbzZpHZAPfcDuN_eUw33kGD2vMVMXInGPA35h-y12mb7uzmP2d3F-N7-cXC8vruZn15NGg4UJore1Mb7Svp4RtRZrKcEIpcjSjKqmlgqVqqwG08pfCLItENqZBN0o06pj9nObu-7Tv5Hy4FYhN9R1GCmN2UkQ0pbNykJ_vKGPaexjeV1RVgsQypiivu_UWK_Iu3UfVthv3OsPFXC6BU2fcu6pdU0YcAgpDj2GzoFwzx240oF76aBMnLyZeA19z-7S_4eONh9DNz9fbieeAK7Akqk |
| CitedBy_id | crossref_primary_10_1038_s41433_023_02743_1 crossref_primary_10_1016_j_ajo_2025_07_015 crossref_primary_10_1097_MD_0000000000024670 crossref_primary_10_1111_opo_13545 crossref_primary_10_1038_s41598_020_74348_7 crossref_primary_10_1007_s00417_022_05901_5 crossref_primary_10_1038_s41433_023_02558_0 crossref_primary_10_1007_s10633_020_09806_8 crossref_primary_10_1016_j_ophtha_2022_06_024 crossref_primary_10_1097_ICU_0000000000000571 crossref_primary_10_1007_s00371_023_03189_y crossref_primary_10_1093_pubmed_fdae006 crossref_primary_10_1136_bjophthalmol_2019_314752 crossref_primary_10_1038_s41746_024_01204_7 crossref_primary_10_1186_s12967_019_2057_2 crossref_primary_10_2147_OPTH_S420631 crossref_primary_10_1186_s12889_025_24064_6 crossref_primary_10_1080_08820538_2022_2087474 crossref_primary_10_1111_opo_13159 crossref_primary_10_1186_s13063_023_07799_8 crossref_primary_10_1038_s41598_024_59602_6 crossref_primary_10_1186_s12916_025_04136_5 crossref_primary_10_1073_pnas_2018840118 crossref_primary_10_1111_opo_13530 crossref_primary_10_1136_bjophthalmol_2021_319431 crossref_primary_10_1007_s10384_020_00733_4 crossref_primary_10_1155_2022_1004977 crossref_primary_10_1002_14651858_CD014758_pub3 crossref_primary_10_1186_s12889_023_15532_y crossref_primary_10_1111_aos_15002 |
| Cites_doi | 10.1016/j.ophtha.2017.12.011 10.1167/iovs.16-20243 10.1001/jama.2015.10803 10.1016/j.ophtha.2012.11.009 10.1016/S0002-9394(99)00455-9 10.1016/j.ajo.2013.08.010 10.1167/iovs.06-1118 10.1016/S0140-6736(12)60272-4 10.1186/s12886-015-0052-9 10.1111/aos.13403 10.1016/j.ophtha.2016.01.006 10.1371/journal.pone.0154671 |
| ContentType | Journal Article |
| Copyright | 2018 Royal Australian and New Zealand College of Ophthalmologists 2018 Royal Australian and New Zealand College of Ophthalmologists. 2019 Royal Australian and New Zealand College of Ophthalmologists |
| Copyright_xml | – notice: 2018 Royal Australian and New Zealand College of Ophthalmologists – notice: 2018 Royal Australian and New Zealand College of Ophthalmologists. – notice: 2019 Royal Australian and New Zealand College of Ophthalmologists |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 |
| DOI | 10.1111/ceo.13391 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1442-9071 |
| EndPage | 178 |
| ExternalDocumentID | 30207041 10_1111_ceo_13391 CEO13391 |
| Genre | article Multicenter Study Comparative Study Randomized Controlled Trial Journal Article |
| GeographicLocations | China Shanghai China |
| GeographicLocations_xml | – name: China – name: Shanghai China |
| GrantInformation_xml | – fundername: Key Discipline of Public Health ‐Eye health in Shanghai funderid: 15GWZK0601 – fundername: Three‐year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (2015‐2017) funderid: GWIV‐13.2 – fundername: Three‐year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (2011‐2013) funderid: 2011‐15 – fundername: Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai funderid: 2017YQ019 – fundername: Brien Holden Vision Institute, Australia |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OC 29B 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KTM LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX CITATION O8X AAHHS ACCFJ ADZOD AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE CGR CUY CVF ECM EIF NPM WRC 7TK K9. 7X8 |
| ID | FETCH-LOGICAL-c4191-aad9b77d64db5eef9ab2217033e9e5e6cb23a3369417f28a12fdb51f5214c37f3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 37 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000462612000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1442-6404 1442-9071 |
| IngestDate | Thu Oct 02 05:57:31 EDT 2025 Sat Nov 29 14:34:41 EST 2025 Wed Feb 19 02:30:10 EST 2025 Sat Nov 29 03:30:32 EST 2025 Tue Nov 18 22:46:20 EST 2025 Tue Sep 09 05:10:54 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | outdoor myopia intervention children prevention |
| Language | English |
| License | 2018 Royal Australian and New Zealand College of Ophthalmologists. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4191-aad9b77d64db5eef9ab2217033e9e5e6cb23a3369417f28a12fdb51f5214c37f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-8938-1879 0000-0002-4453-611X 0000-0002-4246-4343 |
| PMID | 30207041 |
| PQID | 2194010377 |
| PQPubID | 1006520 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_2102921092 proquest_journals_2194010377 pubmed_primary_30207041 crossref_citationtrail_10_1111_ceo_13391 crossref_primary_10_1111_ceo_13391 wiley_primary_10_1111_ceo_13391_CEO13391 |
| PublicationCentury | 2000 |
| PublicationDate | March 2019 |
| PublicationDateYYYYMMDD | 2019-03-01 |
| PublicationDate_xml | – month: 03 year: 2019 text: March 2019 |
| PublicationDecade | 2010 |
| PublicationPlace | Melbourne |
| PublicationPlace_xml | – name: Melbourne – name: Australia – name: Surry Hills |
| PublicationTitle | Clinical & experimental ophthalmology |
| PublicationTitleAlternate | Clin Exp Ophthalmol |
| PublicationYear | 2019 |
| Publisher | John Wiley & Sons Australia, Ltd Wiley Subscription Services, Inc |
| Publisher_xml | – name: John Wiley & Sons Australia, Ltd – name: Wiley Subscription Services, Inc |
| References | 2017; 95 2015; 15 2015; 314 2000; 129 2018; 125 2016; 123 2017 2013; 120 2012; 379 2016; 57 2007; 48 2014; 157 2016; 11 e_1_2_8_14_1 He X (e_1_2_8_13_1) 2017 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_12_1 |
| References_xml | – volume: 314 start-page: 1142 year: 2015 end-page: 1148 article-title: Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial publication-title: JAMA – year: 2017 article-title: Design and methodology of the Shanghai child and adolescent large‐scale eye study (SCALE) publication-title: Clin Experiment Ophthalmol – volume: 15 start-page: 73 year: 2015 article-title: Effect of outdoor activity on myopia onset and progression in school‐aged children in northeast China: the Sujiatun eye care study publication-title: BMC Ophthalmol – volume: 379 start-page: 1739 year: 2012 end-page: 1748 article-title: Myopia publication-title: Lancet – volume: 11 start-page: e0154671 year: 2016 article-title: Near work related behaviors associated with myopic shifts among primary school students in the Jiading District of Shanghai: a school‐based one‐year cohort study publication-title: PLoS One – volume: 57 start-page: 6188 year: 2016 end-page: 6196 article-title: Age‐specific prevalence of visual impairment and refractive error in children aged 3‐10 years in Shanghai, China publication-title: Invest Ophthalmol Vis Sci – volume: 48 start-page: 3524 year: 2007 end-page: 3532 article-title: Parental history of myopia, sports and outdoor activities, and future myopia publication-title: Invest Ophthalmol Vis Sci – volume: 123 start-page: 1036 year: 2016 end-page: 1042 article-title: Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050 publication-title: Ophthalmology – volume: 125 start-page: 1239 year: 2018 end-page: 1250 article-title: Myopia prevention and outdoor light intensity in a school‐based cluster randomized trial publication-title: Ophthalmology – volume: 129 start-page: 421 year: 2000 end-page: 426 article-title: Refractive error study in children: sampling and measurement methods for a multi‐country survey publication-title: Am J Ophthalmol – volume: 120 start-page: 1080 year: 2013 end-page: 1085 article-title: Outdoor activity during class recess reduces myopia onset and progression in school children publication-title: Ophthalmology – volume: 157 start-page: 9 year: 2014 end-page: 25.e12 article-title: Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence‐based systematic review publication-title: Am J Ophthalmol – volume: 95 start-page: 551 year: 2017 end-page: 566 article-title: Time spent in outdoor activities in relation to myopia prevention and control: a meta‐analysis and systematic review publication-title: Acta Ophthalmol – ident: e_1_2_8_8_1 doi: 10.1016/j.ophtha.2017.12.011 – year: 2017 ident: e_1_2_8_13_1 article-title: Design and methodology of the Shanghai child and adolescent large‐scale eye study (SCALE) publication-title: Clin Experiment Ophthalmol – ident: e_1_2_8_11_1 doi: 10.1167/iovs.16-20243 – ident: e_1_2_8_5_1 doi: 10.1001/jama.2015.10803 – ident: e_1_2_8_6_1 doi: 10.1016/j.ophtha.2012.11.009 – ident: e_1_2_8_12_1 doi: 10.1016/S0002-9394(99)00455-9 – ident: e_1_2_8_3_1 doi: 10.1016/j.ajo.2013.08.010 – ident: e_1_2_8_14_1 doi: 10.1167/iovs.06-1118 – ident: e_1_2_8_2_1 doi: 10.1016/S0140-6736(12)60272-4 – ident: e_1_2_8_7_1 doi: 10.1186/s12886-015-0052-9 – ident: e_1_2_8_9_1 doi: 10.1111/aos.13403 – ident: e_1_2_8_4_1 doi: 10.1016/j.ophtha.2016.01.006 – ident: e_1_2_8_10_1 doi: 10.1371/journal.pone.0154671 |
| SSID | ssj0005236 |
| Score | 2.3866751 |
| Snippet | Importance
Myopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia.
Background
To... Myopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia. To describe the methodology... ImportanceMyopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia.BackgroundTo describe... Myopia is a major public health concern worldwide, while outdoor time is indicated to be protective against the onset of myopia.IMPORTANCEMyopia is a major... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 171 |
| SubjectTerms | Child Children China - epidemiology Cluster Analysis Female Humans Incidence intervention Male Myopia Myopia - epidemiology Myopia - prevention & control Ophthalmology outdoor Outdoors Prevalence prevention Prospective Studies Public health Recreation - physiology Refraction, Ocular Research Design Schools Surveys and Questionnaires |
| Title | Shanghai Time Outside to Reduce Myopia trial: design and baseline data |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fceo.13391 https://www.ncbi.nlm.nih.gov/pubmed/30207041 https://www.proquest.com/docview/2194010377 https://www.proquest.com/docview/2102921092 |
| Volume | 47 |
| WOSCitedRecordID | wos000462612000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1442-9071 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005236 issn: 1442-6404 databaseCode: DRFUL dateStart: 20000101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LSsQwcNBVxIvvx_pYonjwUtlN0ibRk-guHnzhA_ZWpkmKC9KKuyv49yZttygqCF5KoZMmzCMzk8wD4MDpDEGNTgKpkQfcWBqo0ERBpDWPpJEh10XXkktxfS37fXU7BSeTXJiyPkR94OYlo9ivvYBjMvwk5NrmR87B8pnrM9TxbdiAmfO73uPlpwgPViYXcRpEvM2rwkI-kKce_FUdfbMxv5qshc7pLf5rtUuwUJma5LTkjWWYstkKzF1Vl-mr0Lv3h8VPOCA-D4TcjEe-dScZ5eTO13O15Oo9fxkgKRp7HBNTxHoQzAzxqs8vifj40jV47HUfzi6Cqq1CoLnzzgJEoxIhTMRNElqbKkyoc0zajFllQxvphDJkzGe4ipRK7NDUAXZSp-i5ZiJl69DI8sxuAkGLqdIdg84P44J1UIZSmRTR7QuhsrIJhxPsxrqqOe5bXzzHE9_D4SUu8NKE_Rr0pSy08RPQzoREcSVrw9jtudx3qxCiCXv1Zycl_uoDM5uPPUybKvdQtAkbJWnrWZizmEWbu58fFhT8ffr4rHtTvGz9HXQb5p2NpcqwtR1ojF7Hdhdm9dtoMHxtwbToy1bFuB-r5uzu |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1NT9sw9AlRBLsMBmx0MDCIA5eg1nbieNplYlRFawviQ-IWObajVUIJgnYS_573kjQqYkiTuESR8hxbft_2-wA4RJ2huLNpEFsjA-k8D3TooiCyVkaxi0Npy64lAzUaxbe3-mIBfsxyYar6EM2BG3FGKa-JwelAeo7LrS-O0cOi1PWWRDJC-m79uuzdDOZCPESVXSR5EMmOrCsLUSRPM_ilPnplZL60WUul01t933LX4GNtbLKfFXV8ggWfr8PysL5O34DeFR0X_zFjRpkg7Hw6oeadbFKwS6ro6tnwqbgfG1a29vjOXBntwUzuGCk_WhOjCNNNuOmdXp_0g7qxQmAl-meBMU6nSrlIujT0PtMm5eiadITw2oc-sikXRgjKcVUZj02XZwjYzVDVSytUJj7DYl7kfguY8SbTtusMemJSia6Jw1i7zBiUDKH2cRuOZtub2LrqODW_uEtm3gfuS1LuSxsOGtD7qtTGv4B2ZjhKam57TFDqSupXoVQb9pvPyCd0-WFyX0wJpsM1PjRvw5cKt80sAm1m1ZH486MShW9Pn5ycnpcvX_8fdA9W-tfDQTI4G_3ehg9ocekqiG0HFicPU_8NluzfyfjxYbem32dPWe_2 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB5kFfHi-7E-o3jwUtlN0qYRL6IWxXUVH-CtpEmKC9Iu667gvzfTdouiguClFDppwiSTmUlm5gPYdzpDUKMTL9SKe9xY6knfBF6gNQ9CE_pcF6glHdHthk9P8nYCjse5MGV9iPrADSWj2K9RwG3fpJ-kXNv80HlYmLo-yRFEpgGTZ3fRY-dTiAcrs4s49QLe4lVlIYzkqRt_1UffjMyvNmuhdKK5_w13HmYrY5OclKtjASZstgjT19V1-hJE93hc_Kx6BDNByM1oiOCdZJiTO6zoasn1e97vKVJAexwRU0R7EJUZgsoPx0QwwnQZHqPzh9MLrwJW8DR3_pmnlJGJECbgJvGtTaVKqHNNWoxZaX0b6IQyxRjmuIqUhqpNU0fYTp2q55qJlK1AI8szuwZEWZVK3TbKeWJcsLYK_VCaVCm3M_jShk04GLM31lXVcQS_eInH3ofjS1zwpQl7NWm_LLXxE9HmeI7iStpeY7frcsSrEKIJu_VnJyd4-aEym4-QpkWle0jahNVybutemLOZRYu7nx8UU_h79_Hp-U3xsv530h2Yvj2L4s5l92oDZpzBJcsYtk1oDAcjuwVT-m3Yex1sV8v3A_EV73E |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shanghai+Time+Outside+to+Reduce+Myopia+trial%3A+design+and+baseline+data&rft.jtitle=Clinical+%26+experimental+ophthalmology&rft.au=He%2C+Xiangui&rft.au=Sankaridurg%2C+Padmaja&rft.au=Xiong%2C+Shuyu&rft.au=Li%2C+Wayne&rft.date=2019-03-01&rft.pub=John+Wiley+%26+Sons+Australia%2C+Ltd&rft.issn=1442-6404&rft.eissn=1442-9071&rft.volume=47&rft.issue=2&rft.spage=171&rft.epage=178&rft_id=info:doi/10.1111%2Fceo.13391&rft.externalDBID=10.1111%252Fceo.13391&rft.externalDocID=CEO13391 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1442-6404&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1442-6404&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1442-6404&client=summon |